本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Purple Biotech Ltd.

2.69
+0.00340.13%
盤後2.690.00000.00%18:57 EDT
成交量:1.14萬
成交額:3.06萬
市值:711.04萬
市盈率:-0.61
高:2.78
開:2.70
低:2.64
收:2.68
資料載入中...
2025/03/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC問詢函

Form CORRESP - Correspondence
2024/07/22

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC問詢函

Form CORRESP - Correspondence
2023/04/03

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/02

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals